Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide different risk estimates at the individual patient le...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:NPJ Breast Cancer
Auteurs principaux: Bartlett, John M. S., Bayani, Jane, Kornaga, Elizabeth, Xu, Keying, Pond, Greg R., Piper, Tammy, Mallon, Elizabeth, Yao, Cindy Q., Boutros, Paul C., Hasenburg, Annette, Dunn, J. A., Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, van de Velde, Cornelis J. H., Stein, Robert C., Rea, Daniel
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266887/
https://ncbi.nlm.nih.gov/pubmed/34238931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-021-00297-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires